Everyone’s heard about the $1,000 genome test. How useful will it be? What are the ramifications of direct to consumer (DTC) genetic and sexually transmissible disease testing? Come to this session on molecular diagnostic testing to learn the basics of this rapidly changing field, including the difference between lab-developed and FDA-approved tests. Hear a panel of experts discuss topics such as reimbursement (physician fees or lab tests?), regulatory challenges, role of genetic counseling, use of companion diagnostics in targeted therapy, point of care molecular diagnostic testing, and molecular testing for infectious diseases.
